9397-2677 Québec inc.
$99,900.00 CAD
≈ 15 months of average Canadian pay
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2024-2025
- Agreement period
- April 15, 2024 – March 31, 2025
- Reference
- nrc-cnrc:172-2024-2025-Q1-1017172
Published purpose
The main human-derived tumor models (cell lines, xenografts and organoids) do not preserve the immune cells of the tumor from which they are derived. This limits the ability to effectively predict the effect of cancer immunotherapies in humans, and the ability to de-risk clinical validation. This project aims to characterize the immune microenvironment of human tumor explants and demonstrate its ability to measure an immune and cytotoxic response to a treatment applied ex vivo.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported July 30, 2026 from open.canada.ca Grants & Contributions